Rituximab is useful in the treatment of Felty's syndrome

American Journal of Therapeutics

Volumn 15, Issue 4, 2008, Pages 321-322

  Chandra, Preeti A ^a   Margulis, Yevgeniya ^a   Schiff, Carl ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

Felty's syndrome; Neutropenia; Rheumatoid arthritis; Rituximab; Splenomegaly

Indexed keywords

AURANOFIN; COLCHICINE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; PENICILLAMINE; PREDNISONE; RITUXIMAB; ANTIRHEUMATIC AGENT; MONOCLONAL ANTIBODY;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; FELTY SYNDROME; HUMAN; LEUKOPENIA; MALE; NEUTROPHIL; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; SPLENOMEGALY; TREATMENT OUTCOME; DRUG EFFECT; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK FACTOR;

ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; FELTY'S SYNDROME; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; PAIN; RISK FACTORS;

EID: 51649108185     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318164bf32     Document Type: Article

References (6)

1. Balint GP, Balint PV. Felty's syndrome [Review]. Best Pract Res Clin Rheumatol. 2004;18:631-645.
2. Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome [Review]. Blood Rev. 2006;20:245-266.
3. Almoallim H, Klinkhoff A. Longterm outcome of treatment of Felty's syndrome with intramuscular gold: case reports and recommendations for management. J Rheumatol. 2005; 32:20-26.
4. Ghavami A, Genevay S, Fulpius T, et al. Etanercept in treatment of Felty's syndrome [Review]. Ann Rheum Dis. 2005;64:1090-1091.
5. Sordet C, Gottenberg J-E, Hellmich B, et al. Lack of efficacy of rituximab in Felty's syndrome. Ann Rheum Dis. 2005;64: 332-333.
6. Weinreb N, Rabinowitz A, Dellaripa PF. Beneficial response to rituximab in refractory Felty Syndrome. J Clin Rheumatol. 2006;12:48.